Director – Portfolio Valuation & Decision Analysis
Viatris
Summary
Every day, we rise to the challenge to make a difference and here's how the Director – Portfolio Valuation & Decision Analysis role will make an impact:
Job description
- Partner with Program Leaders and Managers, Global Portfolio Managers, Finance and Commercial and cross-functional teams to evaluate development strategies, investment alternatives, and lifecycle opportunities.
- Support stage-gate reviews and governance decisions through objective assessments of program value, risk, and strategic considerations.
- Provide program teams and decisionmakers with actionable recommendations to support program strategic planning, prioritization, and resource allocation.
- Lead the development and ongoing assessment of program business cases and portfolio value.
- Ensure business cases reflect current development plans, commercial assumptions, competitive dynamics, and investment requirements.
- Proactively identify and communicate material changes in program value, risk, and investment outlook.
- Support evaluation of external opportunities, including licensing, partnerships, and co-development.
- Lead scenario, sensitivity, and risk analyses to evaluate strategic alternatives and key value drivers.
- Assess the impact of development, commercial, regulatory, and market uncertainties on program and portfolio value.
- Deliver insights that support portfolio optimization, long-range planning, and investment decision-making.
- Establish and maintain standards, methodologies, and governance processes for business case development and portfolio valuation.
- Ensure consistent, transparent, and objective evaluation of programs and investment opportunities across the portfolio.
- Drive alignment on key assumptions, decision criteria, and valuation approaches.
Requirements
- Bachelor's degree required in Business Analytics, Decision Sciences, Operations Research, Engineering or related discipline
- Master's degree (MBA, MS, or related advanced degree) preferred
- 10+ years of experience in pharmaceutical, biotechnology, or life sciences organizations
- 6+ years of experience in portfolio management, strategic planning, finance, commercial assessment, or decision analysis
- Demonstrated experience supporting stage-gate reviews, portfolio prioritization, and strategic investment decisions
- Experience working with program teams and senior leadership to support program investment and resource planning decisions
- Deep understanding of pharmaceutical R&D, portfolio management, and product development
- Expertise in business case development, portfolio valuation, financial modeling (NPV), and scenario analysis
- Strong strategic thinking with the ability to evaluate investment opportunities, risks, and trade-offs
- Ability to synthesize scientific, commercial, and financial inputs into clear recommendations for senior leadership
- Strong communication, influencing, and stakeholder management skills in a highly matrixed environment
- Proven ability to support teams and drive evidence-based decision-making
- Ability to read and interpret complex business and/or technical documents
- Ability to write comprehensive reports and detailed business correspondence
- Ability to present to a group of departments
- Understanding of value metrics and how to use them effectively on projects
- Ability to solve complex problems with a variety of variables through nonstandard solutions
- Proficiency in speaking, comprehending, reading and writing English is required
Benefits
- Competitive Salaries
- Inclusive Environment
Company overview
Viatris Inc. is a global pharmaceutical company formed in November 2020 through the merger of Mylan and Pfizer's Upjohn division. Headquartered in Canonsburg, Pennsylvania, the company operates with a mission to empower people worldwide to live healthier at every stage of life. Viatris uniquely bridges the traditional divide between generics and branded medicines, combining the best of both approaches to address healthcare needs globally. With approximately 32,000 employees worldwide, the company maintains a diverse portfolio of over 1,400 approved therapeutic molecules across key areas including cardiovascular, infectious diseases, oncology, immunology, CNS and anesthesia, women's healthcare, diabetes and metabolism, gastroenterology, respiratory and allergy, and dermatology. Viatris operates approximately 40 manufacturing sites across five continents, producing oral solid doses, injectables, complex dosage forms, and active pharmaceutical ingredients. The company's global supply chain is designed to reach patients in more than 165 countries and territories, supplying approximately 1 billion patients annually. Viatris focuses on expanding access to high-quality medicines while developing more complex and novel products to address unmet medical needs.